Don’t miss it! At EUROTOX Congress from 8 – 11 September in Copenhagen, check out our eposter displaying the work of @Ahmed Kousba, BioAgilytix Associate Director of Pharmacokinetics, and his team, represented in person by Scientific Officer Michelle Miller, PhD titled “Toxicokinetics of NIDO-361, a Potential Candidate to treat Spinal and Bulbar Muscular Atrophy (SBMA), in Rats and Monkeys Following Oral Dosing in a 4-Week Toxicity Study.” Be sure to also schedule a meeting with our experts onsite or stop by our booth to discuss how we can support IND-enabling studies for your preclinical toxicology program with accurate measurements of systemic exposure for small or large molecule therapeutic modalities. https://bit.ly/3Mcz2mi #EUROTOX2024 #toxicology #science #InnovationInScience #copenhagen
BioAgilytix
Biotechnology Research
Durham, NC 29,279 followers
Enabling the breakthroughs of tomorrow, today.
Über uns
BioAgilytix is a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development. With laboratory locations in North Carolina’s Research Triangle Park; Cambridge, Massachusetts; San Diego, California; Melbourne and Brisbane, Australia and Hamburg, Germany, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assay services supporting the development and release testing of therapeutics across a number of industries and disease states. BioAgilytix offers assay development, validation, and sample analysis under non-GLP, GLP, and GCP, as well as GMP quality control testing (i.e., product release testing, stability testing, etc.) BioAgilytix also offers diagnostic testing services at its CLIA-certified, CAP-accredited Boston laboratory. BioAgilytix’s team of highly experienced scientific and QA professionals ensures high-quality science, data integrity and regulatory compliance through all phases of clinical development. BioAgilytix is a trusted partner to many top global pharmaceutical and biotech companies. For more information, visit www.bioagilytix.com.
- Website
-
http://www.BioAgilytix.com
External link for BioAgilytix
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 1.001-5.000 Mitarbeiter
- Hauptsitz
- Durham, NC
- Typ
- In Privatbesitz
- Gegründet
- 2008
- Spezialitäten
- Immunoassays, Cell-Based Assays, Immunogenicity, Pharmacokinetics, Biomarkers, Large molecule bioanalysis, Bioanalytical testing, Assay Development & Validation, Bioassays, Biosimilars, Gene Therapy, and Immuno-oncology
Standorte
Employees at BioAgilytix
Aktualisierungen
-
Local to the RTP area? Join us for the Cytiva diagnostics roadshow on Tuesday, August 27th from 9:30am-3:30pm at North Carolina Biotechnology Center (NCBiotech) where BioAgilytix’s Swati Gupta will present an overview of the strategies for improving drug tolerance in immunogenicity testing and how to leverage magnetic beads for challenging assays. At this free event, you will have a chance to explore Cytiva’s innovative diagnostic solutions and services and engage in interactive sessions while enjoying a complimentary lunch and networking in a casual setting with other scientific experts, professionals, and researchers. We can’t wait to see you there! Register here: https://bit.ly/3YZHjBH
-
We hope to see you at EUROTOX Congress held in Copenhagen, Denmark from 8 – 11 September! Visit our booth to speak with our experts about the global, best-in-class bioanalytical services we provide to address even the most challenging TK/PK, Immunogenicity, and Biomarker assay requirements. Scientific Officer Michelle Miller, PhD, Vice President Business Development Europe Stephane de Fortescu, and Director Business Development Europe Ymke Van Der Geld will be on site to answer your questions. Don’t forget to learn about the preclinical toxicokinetics of a novel small molecule therapeutic to treat SBMA, a rare genetic disorder, at our eposter. We can't wait to see you there! Schedule a meeting with us in advance https://bit.ly/3Mcz2mi #EUROTOX2024 #toxicology #science #InnovationInScience #copenhagen
-
Our Scientific Officer, Amanda Hays, PhD shared insights on the evolution of bioanalysis during a presentation on the @Scientist Channel. She delves into the notable progress in gene editing technologies and highlights the crucial role of the American Association of Pharmaceutical Scientists (AAPS) in promoting collaboration among professionals and organizations in diverse scientific domains. To Learn More https://lnkd.in/emzNzFYm
In honor of how far scientific discovery has come since the discovery of DNA, we are excited to announce the launch of our new editorial feature, "Gene Editing: CRISPR & Beyond." Here we explore the latest advancements in gene editing technologies, highlighting how CRISPR is revolutionizing science, medicine, and the future of genetic research. Visit the feature here: https://lnkd.in/e9eYPimP #geneediting #CRISPR #rosalindfranklin #DNA #genetics #genomics #biotech
-
Our team enjoyed being onsite at the American Association of Pharmaceutical Scientists (AAPS) | aapscomms Summer Scientific Forum in Kansas City, MO last week for the annual forum. Our team was thrilled to present on a wide range of topics including considerations around method transfers and validations, guidance on developing ADA assays for ASOs, and validation best practices for PCR-based methods. The meeting offered the team the opportunity to interact with other scientists and discuss recent advances in drug development. We were happy to meet face to face with so many attendees at our booth and discuss how our bioanalytical capabilities can support future Immunogenicity, PK, biomarker, and CMC assay projects. Did you miss us at the Summer Scientific Forum? Be sure to reach out to our scientific team today https://bit.ly/44luZLt
-
BioAgilytix’ CMC Bioanalytical team is expanding, and we’re looking for a Sr. Scientist to help lead our growth! This high-visibility role offers a unique blend of scientific, client, and project oversight while introducing new capabilities in providing more comprehensive support for control strategies. You’ll work on CMC assay development, validation, and sample analysis projects while managing timelines and collaborating with clients. Ideal candidates will have a strong background in working in a GMP-regulated lab, biologics analysis and separation and biophysical science. Join us to make a significant impact in the field! https://bit.ly/4f7qN8p #bioagilyitx #hiring #CMC
-
Attending the American Association of Pharmaceutical Scientists (AAPS) | aapscomms Summer Scientific Forum in Kansas City? Don’t miss the Rapid-Fire presentation by BioAgilytix’s Manoj Kumar Baskaran where Manoj will discuss the potential impact of the draft FDA guidance on potency assay strategies for cell and gene therapies. BioAgilytix has supported over 150 GMP validations/qualifications of potency assays in nearly every biologic modality since 2018. Visit our team of experts onsite at booth 8 to discuss your biologic and ATMP CMC testing questions or needs. https://bit.ly/3We9g72 #immunogenicity #celltherapy #genetherapy #cellandgenetherapy #CMC #PCR #flowcytometry #ASOs #biotherapeutics #biopharma
-
We are gearing up for another exciting annual American Association of Pharmaceutical Scientists (AAPS) | aapscomms Summer Scientific Forum in Kansas City. On July 24th Bryan M. Gullick, Ph.D. will present “Validation Best Practices: PCR Case Studies in Shedding” at 2:35 pm. Our scientific team has a deep level of experience with developing, optimizing, and validating complex molecular assays using qPCR or ddPCR. We take a collaborative approach, leveraging our molecular expertise to ensure your project is a success. Visit our website to learn more and schedule a meeting onsite at booth 8 with our team of experts to discuss your PCR project needs. https://bit.ly/3We9g72 #immunogenicity #celltherapy #genetherapy #cellandgenetherapy #CMC #PCR #flowcytometry #ASOs #biotherapeutics #biopharma
-
Manoj Kumar Baskaran will present at the upcoming American Association of Pharmaceutical Scientists (AAPS) | aapscomms Summer Scientific Forum on the transfer and validation of a flow cytometry assay across platforms and labs. Did you know BioAgilytix can support flow cytometry readouts for assays under non-regulated or regulated (GCLP, CLIA, and GMP) conditions, utilizing a variety of flow cytometry platforms? Our flow cytometry laboratories are staffed with experienced scientific teams that routinely develop assays to support drug development programs across a range of endpoints and applications. Visit our website to learn more about our flow cytometry assay experience and schedule a meeting with our experts onsite at booth 8 in Kansas City. https://bit.ly/3We9g72 #immunogenicity #celltherapy #genetherapy #cellandgenetherapy #CMC #PCR #flowcytometry #ASOs #biotherapeutics #biopharma
-
We are getting excited for the American Association of Pharmaceutical Scientists (AAPS) | aapscomms! Don’t miss @AmandaHays's presentation, where she will highlight the potential challenges associated with bioanalytical method transfers and provide case studies with strategies for overcoming these potential hurdles during the method transfer phase. As a CRO with extensive experience in this space, BioAgilytix has implemented procedures and practices to mitigate these risks and to support successful transfers both internally and externally. Learn more about our strategies for successful method transfers by scheduling a meeting with our team of experts onsite at booth 8. https://bit.ly/3We9g72 #immunogenicity #celltherapy #genetherapy #cellandgenetherapy #CMC #PCR #flowcytometry #ASOs #biotherapeutics #biopharma